{
  "symbol": "INDP",
  "company_name": "Indaptus Therapeutics Inc",
  "ir_website": "https://indaptusrx.com/investors/",
  "structured_data": [
    {
      "section_name": "News Articles",
      "links": [
        {
          "title": "Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement",
          "url": "https://indaptusrx.com/investors/news-releases/",
          "content": "[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [ABOUT US](https://indaptusrx.com/about/company-overview/)Open menu\n    * [Company Overview](https://indaptusrx.com/company-overview/)\n    * [Management](https://indaptusrx.com/about-us/management/)\n    * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n  * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n  * [INVESTORS](https://indaptusrx.com/investors/)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n  * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [ABOUT US](https://indaptusrx.com/about/company-overview/)\n      * [Company Overview](https://indaptusrx.com/company-overview/)\n      * [Management](https://indaptusrx.com/about-us/management/)\n      * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n    * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n    * [INVESTORS](https://indaptusrx.com/investors/)\n      * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n    * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n  * [IR Menu](#)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [News Releases](https://indaptusrx.com/investors/news-releases/)\n      * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n      * [Articles](https://indaptusrx.com/investors/articles/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n      * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n      * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n      * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n      * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n      * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ![](https://indaptusrx.com/investors/wp-content/uploads/2022/09/logo.png) ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases \n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases\n\n[ Events & Presentations ](https://indaptusrx.com/investors/events-presentations/)\n\n[ Articles ](https://indaptusrx.com/investors/articles/)\n\n[Financial Market Data](https://www.quotemedia.com/coverage)copyright © 2022[QuoteMedia](https://www.quotemedia.com/). Market News powered by[QuoteMedia](https://www.quotemedia.com/).[Terms of Use](https://www.quotemedia.com/legal/tos/).\n\n[ ![logo-graphic-large](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-graphic-large-qojwfaumah7ulmht1c159clfs0n6h9gsz5ba14epds.png) ](https://indaptusrx.com/)\n\nAn emerging leader in the immunotherapy space, we are advancing a pre-clinical pipeline of therapeutic candidates intended to elicit broad and durable anti-tumor and anti-viral responses and cure disease. \n\n## ABOUT US\n\n  * [ Company Overview ](https://indaptusrx.com/company-overview/)\n  * [ Management ](https://indaptusrx.com/about-us/management/)\n  * [ Board of Directors ](https://indaptusrx.com/board-of-directors/)\n\n\n\n## [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n\n## [INVESTORS](https://indaptusrx.com/investors/)\n\n  * [ Stock Information ](https://indaptusrx.com/investors/stock-quote-chart/)\n  * [ News & Events ](https://indaptusrx.com/investors/news-releases/)\n  * [ Financial Information ](https://indaptusrx.com/investors/sec-filings/)\n  * [ Corporate Governance ](https://indaptusrx.com/investors/governance-highlights/)\n  * [ IR Resources ](https://indaptusrx.com/investors/contact-us/)\n\n\n\n## [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n![logo](https://indaptusrx.com/investors/wp-content/uploads/2022/10/footerlogo.png)© 2022. Indaptus Therapeutics. All Rights Reserved. | Terms of Use \n"
        },
        {
          "title": "Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update",
          "url": "https://indaptusrx.com/investors/news-releases/",
          "content": "[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [ABOUT US](https://indaptusrx.com/about/company-overview/)Open menu\n    * [Company Overview](https://indaptusrx.com/company-overview/)\n    * [Management](https://indaptusrx.com/about-us/management/)\n    * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n  * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n  * [INVESTORS](https://indaptusrx.com/investors/)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n  * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [ABOUT US](https://indaptusrx.com/about/company-overview/)\n      * [Company Overview](https://indaptusrx.com/company-overview/)\n      * [Management](https://indaptusrx.com/about-us/management/)\n      * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n    * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n    * [INVESTORS](https://indaptusrx.com/investors/)\n      * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n    * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n  * [IR Menu](#)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [News Releases](https://indaptusrx.com/investors/news-releases/)\n      * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n      * [Articles](https://indaptusrx.com/investors/articles/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n      * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n      * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n      * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n      * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n      * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ![](https://indaptusrx.com/investors/wp-content/uploads/2022/09/logo.png) ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases \n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases\n\n[ Events & Presentations ](https://indaptusrx.com/investors/events-presentations/)\n\n[ Articles ](https://indaptusrx.com/investors/articles/)\n\n[Financial Market Data](https://www.quotemedia.com/coverage)copyright © 2022[QuoteMedia](https://www.quotemedia.com/). Market News powered by[QuoteMedia](https://www.quotemedia.com/).[Terms of Use](https://www.quotemedia.com/legal/tos/).\n\n[ ![logo-graphic-large](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-graphic-large-qojwfaumah7ulmht1c159clfs0n6h9gsz5ba14epds.png) ](https://indaptusrx.com/)\n\nAn emerging leader in the immunotherapy space, we are advancing a pre-clinical pipeline of therapeutic candidates intended to elicit broad and durable anti-tumor and anti-viral responses and cure disease. \n\n## ABOUT US\n\n  * [ Company Overview ](https://indaptusrx.com/company-overview/)\n  * [ Management ](https://indaptusrx.com/about-us/management/)\n  * [ Board of Directors ](https://indaptusrx.com/board-of-directors/)\n\n\n\n## [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n\n## [INVESTORS](https://indaptusrx.com/investors/)\n\n  * [ Stock Information ](https://indaptusrx.com/investors/stock-quote-chart/)\n  * [ News & Events ](https://indaptusrx.com/investors/news-releases/)\n  * [ Financial Information ](https://indaptusrx.com/investors/sec-filings/)\n  * [ Corporate Governance ](https://indaptusrx.com/investors/governance-highlights/)\n  * [ IR Resources ](https://indaptusrx.com/investors/contact-us/)\n\n\n\n## [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n![logo](https://indaptusrx.com/investors/wp-content/uploads/2022/10/footerlogo.png)© 2022. Indaptus Therapeutics. All Rights Reserved. | Terms of Use \n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "Statement of changes in beneficial ownership of securities",
          "url": "https://app.quotemedia.com/data/downloadFiling?webmasterId=104583&ref=318750115&type=HTML&symbol=INDP&cdn=d8ea75b02bce344fb14de3b9ac53e4eb&companyName=Indaptus+Therapeutics+Inc.&formType=4&formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&dateFiled=2024-11-26",
          "content": "SEC Form 4  FORM 4 |  UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940 |  | OMB APPROVAL  \n---  \n| OMB Number: | 3235-0287  \n---|---  \nEstimated average burden  \nhours per response: | 0.5  \n![checkbox unchecked](https://cdn.kscope.io/box-unchecked.jpg) | Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. _See_ Instruction 1(b).  \n![checkbox unchecked](https://cdn.kscope.io/box-unchecked.jpg) | Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.  \n1. Name and Address of Reporting Person*| [Meckler Jeffrey A](http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001506916)  \n---  \n(Last) | (First) | (Middle)  \n---|---|---  \nC/O INDAPTUS THERAPEUTICS, INC  \n---  \n3 COLUMBUS CIRCLE, 15TH FLOOR  \n(Street) NEW YORK | NY | 10019  \n---|---|---  \n(City) | (State) | (Zip)  \n---|---|---  \n2. Issuer Name **and** Ticker or Trading Symbol [Indaptus Therapeutics, Inc.](http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001857044) [ INDP ]  |  5. Relationship of Reporting Person(s) to Issuer (Check all applicable) | ![checkbox checked](https://cdn.kscope.io/box-checked.jpg) | Director | 10% Owner  \n---|---|---  \n![checkbox checked](https://cdn.kscope.io/box-checked.jpg) | Officer (give title below) | Other (specify below)  \nCEO and Director  \n3. Date of Earliest Transaction (Month/Day/Year)11/25/2024  \n4. If Amendment, Date of Original Filed (Month/Day/Year) |  6. Individual or Joint/Group Filing (Check Applicable Line)  | ![checkbox checked](https://cdn.kscope.io/box-checked.jpg) | Form filed by One Reporting Person  \n---|---  \nForm filed by More than One Reporting Person  \n**Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned**  \n---  \n1. Title of Security (Instr. 3)  | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8)  | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)  | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)  | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)  | 7. Nature of Indirect Beneficial Ownership (Instr. 4)   \nCode | V | Amount | (A) or (D) | Price  \nCommon stock | 11/25/2024 | A | 42,553 | A |  $1.175(1) | 202,859 | D  \n**Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned****(e.g., puts, calls, warrants, options, convertible securities)**  \n---  \n1. Title of Derivative Security (Instr. 3)  | 2. Conversion or Exercise Price of Derivative Security  | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8)  | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)  | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)  | 8. Price of Derivative Security (Instr. 5)  | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)  | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)  | 11. Nature of Indirect Beneficial Ownership (Instr. 4)   \nCode | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares  \nCommon Stock Warrants |  $1.05 | 11/25/2024 | A | 42,553 |  (1) | 11/25/2029 | Common Stock | 42,553 |  $1.175(1) | 42,553 | D  \n**Explanation of Responses:**  \n---  \n1. The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78.  \n_/s/ Jeffrey Meckler_ | _11/26/2024_  \n---|---  \n** Signature of Reporting Person | Date  \nReminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.  \n* If the form is filed by more than one reporting person, _see_ Instruction 4 (b)(v).  \n** Intentional misstatements or omissions of facts constitute Federal Criminal Violations _See_ 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).  \nNote: File three copies of this Form, one of which must be manually signed. If space is insufficient, _see_ Instruction 6 for procedure.  \n**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**\n"
        },
        {
          "title": "[Amend] General statement of acquisition of beneficial ownership",
          "url": "https://app.quotemedia.com/data/downloadFiling?webmasterId=104583&ref=318750293&type=HTML&symbol=INDP&cdn=13af25ecec429328d0ccf7f002810c64&companyName=Indaptus+Therapeutics+Inc.&formType=SC+13D%2FA&formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&dateFiled=2024-11-26",
          "content": ""
        }
      ]
    },
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement",
          "url": "https://indaptusrx.com/investors/news-releases/",
          "content": "[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [ABOUT US](https://indaptusrx.com/about/company-overview/)Open menu\n    * [Company Overview](https://indaptusrx.com/company-overview/)\n    * [Management](https://indaptusrx.com/about-us/management/)\n    * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n  * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n  * [INVESTORS](https://indaptusrx.com/investors/)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n  * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [ABOUT US](https://indaptusrx.com/about/company-overview/)\n      * [Company Overview](https://indaptusrx.com/company-overview/)\n      * [Management](https://indaptusrx.com/about-us/management/)\n      * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n    * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n    * [INVESTORS](https://indaptusrx.com/investors/)\n      * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n    * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n  * [IR Menu](#)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [News Releases](https://indaptusrx.com/investors/news-releases/)\n      * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n      * [Articles](https://indaptusrx.com/investors/articles/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n      * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n      * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n      * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n      * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n      * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ![](https://indaptusrx.com/investors/wp-content/uploads/2022/09/logo.png) ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases \n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases\n\n[ Events & Presentations ](https://indaptusrx.com/investors/events-presentations/)\n\n[ Articles ](https://indaptusrx.com/investors/articles/)\n\n[Financial Market Data](https://www.quotemedia.com/coverage)copyright © 2022[QuoteMedia](https://www.quotemedia.com/). Market News powered by[QuoteMedia](https://www.quotemedia.com/).[Terms of Use](https://www.quotemedia.com/legal/tos/).\n\n[ ![logo-graphic-large](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-graphic-large-qojwfaumah7ulmht1c159clfs0n6h9gsz5ba14epds.png) ](https://indaptusrx.com/)\n\nAn emerging leader in the immunotherapy space, we are advancing a pre-clinical pipeline of therapeutic candidates intended to elicit broad and durable anti-tumor and anti-viral responses and cure disease. \n\n## ABOUT US\n\n  * [ Company Overview ](https://indaptusrx.com/company-overview/)\n  * [ Management ](https://indaptusrx.com/about-us/management/)\n  * [ Board of Directors ](https://indaptusrx.com/board-of-directors/)\n\n\n\n## [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n\n## [INVESTORS](https://indaptusrx.com/investors/)\n\n  * [ Stock Information ](https://indaptusrx.com/investors/stock-quote-chart/)\n  * [ News & Events ](https://indaptusrx.com/investors/news-releases/)\n  * [ Financial Information ](https://indaptusrx.com/investors/sec-filings/)\n  * [ Corporate Governance ](https://indaptusrx.com/investors/governance-highlights/)\n  * [ IR Resources ](https://indaptusrx.com/investors/contact-us/)\n\n\n\n## [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n![logo](https://indaptusrx.com/investors/wp-content/uploads/2022/10/footerlogo.png)© 2022. Indaptus Therapeutics. All Rights Reserved. | Terms of Use \n"
        },
        {
          "title": "Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update",
          "url": "https://indaptusrx.com/investors/news-releases/",
          "content": "[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [ABOUT US](https://indaptusrx.com/about/company-overview/)Open menu\n    * [Company Overview](https://indaptusrx.com/company-overview/)\n    * [Management](https://indaptusrx.com/about-us/management/)\n    * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n  * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n  * [INVESTORS](https://indaptusrx.com/investors/)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n  * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n[ ![logo](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-qojwfaumah7a515ip9coq8rfe66z7dhmdntg05vr40.png) ](https://indaptusrx.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [ABOUT US](https://indaptusrx.com/about/company-overview/)\n      * [Company Overview](https://indaptusrx.com/company-overview/)\n      * [Management](https://indaptusrx.com/about-us/management/)\n      * [Board of Directors](https://indaptusrx.com/board-of-directors/)\n    * [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n    * [INVESTORS](https://indaptusrx.com/investors/)\n      * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n    * [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n  * [IR Menu](#)Open menu\n    * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n      * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n    * [News & Events](https://indaptusrx.com/investors/news-releases/)\n      * [News Releases](https://indaptusrx.com/investors/news-releases/)\n      * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n      * [Articles](https://indaptusrx.com/investors/articles/)\n    * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)\n      * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n      * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n    * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)\n      * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n      * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n      * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n    * [IR Resources](https://indaptusrx.com/investors/contact-us/)\n      * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n      * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ![](https://indaptusrx.com/investors/wp-content/uploads/2022/09/logo.png) ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases \n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\n  * [Stock Information](https://indaptusrx.com/investors/stock-quote-chart/)Open menu\n    * [Stock Quote & Chart](https://indaptusrx.com/investors/stock-quote-chart/)\n    * [Analyst Coverage](https://indaptusrx.com/investors/analyst-coverage/)\n  * [News & Events](https://indaptusrx.com/investors/news-releases/)Open menu\n    * [News Releases](https://indaptusrx.com/investors/news-releases/)\n    * [Events & Presentations](https://indaptusrx.com/investors/events-presentations/)\n    * [Articles](https://indaptusrx.com/investors/articles/)\n  * [Financial Informations](https://indaptusrx.com/investors/sec-filings/)Open menu\n    * [SEC Filings](https://indaptusrx.com/investors/sec-filings/)\n    * [Annual Meeting](https://indaptusrx.com/investors/annual-meeting/)\n  * [Corporate Governance](https://indaptusrx.com/investors/governance-highlights/)Open menu\n    * [Governance Highlights](https://indaptusrx.com/investors/governance-highlights/)\n    * [Board of Directors](https://indaptusrx.com/investors/board-of-directors/)\n    * [Committee Composition](https://indaptusrx.com/investors/committee-composition/)\n  * [IR Resources](https://indaptusrx.com/investors/contact-us/)Open menu\n    * [Contact Us](https://indaptusrx.com/investors/contact-us/)\n    * [Email Alerts](https://indaptusrx.com/investors/email-alerts/)\n\n\n\n[ ](https://indaptusrx.com/investors)\n\nX\n\nNews Releases\n\n[ Events & Presentations ](https://indaptusrx.com/investors/events-presentations/)\n\n[ Articles ](https://indaptusrx.com/investors/articles/)\n\n[Financial Market Data](https://www.quotemedia.com/coverage)copyright © 2022[QuoteMedia](https://www.quotemedia.com/). Market News powered by[QuoteMedia](https://www.quotemedia.com/).[Terms of Use](https://www.quotemedia.com/legal/tos/).\n\n[ ![logo-graphic-large](https://indaptusrx.com/investors/wp-content/uploads/elementor/thumbs/logo-graphic-large-qojwfaumah7ulmht1c159clfs0n6h9gsz5ba14epds.png) ](https://indaptusrx.com/)\n\nAn emerging leader in the immunotherapy space, we are advancing a pre-clinical pipeline of therapeutic candidates intended to elicit broad and durable anti-tumor and anti-viral responses and cure disease. \n\n## ABOUT US\n\n  * [ Company Overview ](https://indaptusrx.com/company-overview/)\n  * [ Management ](https://indaptusrx.com/about-us/management/)\n  * [ Board of Directors ](https://indaptusrx.com/board-of-directors/)\n\n\n\n## [SCIENCE & PIPELINE](https://indaptusrx.com/science-pipeline/)\n\n## [INVESTORS](https://indaptusrx.com/investors/)\n\n  * [ Stock Information ](https://indaptusrx.com/investors/stock-quote-chart/)\n  * [ News & Events ](https://indaptusrx.com/investors/news-releases/)\n  * [ Financial Information ](https://indaptusrx.com/investors/sec-filings/)\n  * [ Corporate Governance ](https://indaptusrx.com/investors/governance-highlights/)\n  * [ IR Resources ](https://indaptusrx.com/investors/contact-us/)\n\n\n\n## [CONTACT US](https://indaptusrx.com/investors/contact-us/)\n\n![logo](https://indaptusrx.com/investors/wp-content/uploads/2022/10/footerlogo.png)© 2022. Indaptus Therapeutics. All Rights Reserved. | Terms of Use \n"
        }
      ]
    },
    {
      "section_name": "Events & Presentations",
      "links": [
        {
          "title": "Jefferies Global Healthcare Conference - Webcast Link",
          "url": "https://wsw.com/webcast/jeff302/register.aspx?conf=jeff302&page=indp&url=https://wsw.com/webcast/jeff302/indp/1838384",
          "content": "![Jefferies](/images/resources/jefferies20120920/images/mm_logo.png)\n\n  * [CONFERENCES](https://www.jefferies.com/OurFirm/ConferenceList/Investment-Conferences/159)\n  * [JEFFERIES HOME](https://www.jefferies.com/)\n\n\n\n# Jefferies Global Healthcare Conference\n\n## June 4th - 6th, 2024\n\nTo register for the webcast, please enter your information in the form below.\n\nEvent: |  Jefferies Global Healthcare Conference  \n---|---  \nPresentation: |  Indaptus Therapeutics  \nTime: |  6/5/2024 8:00 AM (ET)  \n  \nFirst Name* |  First name required  \n---|---  \nLast Name* |  First and last name cannot be the same. Last name required  \nCompany Name* |  Company name required  \nEmail* |  Email required Email is not valid  \n* Required Field  \n  \nYou must have cookies enabled in order to register for this event\n\n[![Summitcast](/images/resources/images/summitcast_logo_sm_black.png)](https://twstevents.com/divisions/summitcast)\n"
        },
        {
          "title": "H.C. Wainwright 25th Annual Global Investment Conference - Webcast Link",
          "url": "https://journey.ct.events/view/a2bb617e-99c0-4e6c-8b4a-15d80a10a66f",
          "content": ""
        }
      ]
    }
  ]
}